Not finding it? Sign in to also search OpenAlex live.
-
Nintedanib Targets KIT D816V Neoplastic Cells Derived from Induced Pluripotent Stem cells of Systemic Mastocytosis2020 bioRxiv (Cold Spring Harbor Laboratory) preprint Immunology and Microbiology Mast cells and histamine Open access
Marcelo A. S. Toledo, Malrun Gatz, Stephanie Sontag, Karoline Veronika Gleixner, Gregor Eisenwort, Kristina Feldberg, +21 more
4citations -
Capitalizing on paradoxical activation of the MAPK pathway for treatment of Imatinib-resistant mast cell leukemia2020 bioRxiv (Cold Spring Harbor Laboratory) preprint Immunology and Microbiology Mast cells and histamine Open access
Thomas Wilhelm, Marcelo A. S. Toledo, Ilka Simons, Christian Stuth, Vrinda Mohta, Ronja Isabelle Mülfarth, +7 more
0citations -
Human CEBPA -N AML exhibits enhanced engraftment and a C/EBP α -p30-driven leukemic stem cell program2026 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine Acute Myeloid Leukemia Research Open access
Philomina Sona Peramangalam, Mayuresh Vishwas Konde, Onur Karakaslar, Sebastian Wolf, Shikan Zheng, Akmal Salimov, +10 more
0citations -
Inflammatory response in hematopoietic stem and progenitor cells triggered by activating SHP2 mutations evokes blood defects2020 bioRxiv (Cold Spring Harbor Laboratory) preprint Biochemistry, Genetics and Molecular Biology Protein Tyrosine Phosphatases Open access
Maja Šolman, Sasja Blokzijl-Franke, Florian Piques, Chuan Yan, Qiqi Yang, Marion Strullu, +6 more
0citations -
Isocitrate Dehydrogenase (IDH) 1 and 2 Mutations Predicts Better Outcome in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation: a study of the ALWP of the EBMT
Razan Mohty, Abdul Hamid Bazarbachi, Myriam Labopin, Jordi Esteve, Nicolaus Martin Kröger, Jan J. Cornelissen, +17 more
0citations -
Remission Induction Versus Immediate Allogeneic Hematopoietic Cell Transplantation for Patients with Relapsed or Poor Responsive Acute Myeloid Leukemia (ASAP): A Randomized, Open-Label, Phase 3, Non-Inferiority Trial
Matthias Stelljes, Jan Moritz Middeke, Gesine Bug, Eva Wagner-Drouet, Lutz Peter Müller, Christoph Schmid, +29 more
5citations -
Transformation of primary murine peritoneal mast cells by constitutive KIT activation as a result of lost Cdkn2a/Arf expression2023 bioRxiv (Cold Spring Harbor Laboratory) preprint Immunology and Microbiology Mast cells and histamine Open access
Sandro Capellmann, Herdit M. Schüler, Steffen K. Meurer, Lin Gan, Marlies Kauffmann, Katharina Horn, +4 more
0citations -
GSTM1 and GSTT1 Double Null Genotypes Determining Cell Fate and Proliferation as Potential Risk Factors of Relapse in Children with Hematological Malignancies after Stem Cell Transplantation.2021 Research Square preprint Biochemistry, Genetics and Molecular Biology Glutathione Transferases and Polymorphisms Open access
Simona Jurković Mlakar, Chakradhara Rao S. Uppugunduri, Tiago Nava, Vid Mlakar, Hadrien G. Golay, Shannon K. D. Robin, +11 more
1citations -
Allogeneic Hematopoietic Cell Transplantation in Patients with Therapy-Related Myeloid Neoplasm after Breast Cancer: A Study of the Chronic Malignancies Working Party of the EBMT
Mitja Nabergoj, Katya A. L. Mauff, Dietrich Wilhelm Beelen, Arnold Ganser, Nicolaus Kröger, Friedrich Stölzel, +19 more
0citations -
DNMT3A knockouts in human iPSCs prevent de novo DNA methylation and reveal growth advantage during hematopoietic differentiation2021 bioRxiv (Cold Spring Harbor Laboratory) preprint Biochemistry, Genetics and Molecular Biology Epigenetics and DNA Methylation Open access
Olivia Cypris, Julia Franzen, Joana Frobel, Philipp Glück, Chao‐Chung Kuo, Stephani Schmitz, +3 more
0citations -
Melatonin nanoparticles inhibit mutant hematopoiesis & restore bone marrow architecture in myeloproliferative neoplasms2026 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Siddharth Gupta, Alessandro Motta, Sara Elsafy, Shiva Khorshid, Alessia Nucci, Vishrutha Sampath, +21 more
0citations -
In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT
Meral Beksaç, Dirk‐Jan Eikema, Linda Köster, Cyrille Hulin, Xavier Poiré, Rose‐Marie Hamladji, +19 more
0citations
19 results